Naloxone reverses an opioid overdose by knocking opioids off their receptors in the brain, restoring breathing within minutes. The most common form available to bystanders is a nasal spray (sold under the brand name Narcan and as generics), which requires no medical training to use: you insert the nozzle into one nostril and press the plunger. But getting the drug into someone’s body is only one step in a sequence that also involves calling emergency services, monitoring breathing, and being ready to give a second dose. The details of that sequence matter, and they have shifted in the fentanyl era.
Recognizing an Opioid Overdose
Before you can administer naloxone, you need to recognize that someone is in trouble. The classic signs of an opioid overdose are slow, shallow, or stopped breathing; blue or grayish lips and fingertips; pinpoint pupils; unresponsiveness to loud voices or a firm rub on the sternum; and a limp body. Snoring or gurgling sounds that might seem like deep sleep are often a warning that the airway is partially obstructed. The person will not wake up if you shake them or shout their name.
Training programs that teach laypeople these signs have proven remarkably effective. One evaluation of six U.S. overdose-training and naloxone-distribution programs found that trained participants recognized opioid overdose scenarios and knew when naloxone was appropriate at levels matching those of medical experts.1Wiley Online Library / Addiction. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States You do not need a medical degree to save someone’s life here. If you are unsure whether the situation is an opioid overdose, giving naloxone is still the right call: the drug has essentially no effect on someone who does not have opioids in their system.
Step by Step With Nasal Spray
The intranasal form is what most bystanders will have on hand. It comes as a single-use device pre-loaded with a fixed dose (currently 4 mg in the most widely distributed product, though an 8 mg version also exists). Here is the sequence:
- Call 911 first: Even if naloxone works perfectly, the person still needs professional medical evaluation. Dial emergency services before or immediately after giving the spray. If someone else is present, have them call while you administer the drug.
- Open the package: Peel back the packaging. Do not test the device or press the plunger until you are ready to deliver the dose.
- Position the person: Lay them on their back. Tilt the head back slightly to open the airway.
- Insert and spray: Place the tip of the nozzle into one nostril, supporting the back of the neck with your other hand. Press the plunger firmly to release the full dose. There is no need to split between nostrils.
- Wait and watch: You should see some response within two to three minutes. Look for any improvement in breathing, changes in skin color, or attempts to move.
- Repeat if needed: If there is no improvement after two to three minutes, give a second dose in the other nostril using a new device. You can continue giving additional doses every two to three minutes if breathing does not resume.
One thing worth knowing: intranasal naloxone reaches the bloodstream more slowly than an injection. The nasal route has a bioavailability of roughly 50%, meaning about half the drug actually gets absorbed, and peak blood levels take around 15 to 30 minutes to arrive.2PubMed Central. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone Pharmacokinetic studies of nasal naloxone formulations have confirmed this timeline, with time to peak concentration averaging around 18 minutes.3PubMed. Pharmacokinetics of a new, nasal formulation of naloxone That does not mean you should panic if you don’t see instant results; the drug starts working before it hits its peak. But it does mean patience and repeat dosing are built into the process.
Intramuscular Injection
Some naloxone kits come with a vial and syringe rather than a nasal spray. Emergency medical services typically use an intramuscular (IM) or intravenous (IV) injection because these routes deliver the drug faster. For bystanders with an IM kit, the standard injection site is the outer thigh, which can be done through clothing if necessary. Draw the naloxone into the syringe, insert the needle at a 90-degree angle into the outer middle thigh, and press the plunger.
The intramuscular route gets naloxone into the bloodstream faster than a nasal spray and with higher bioavailability. Research into alternative IM injection sites has even explored the dorsal forearm, finding roughly 87% bioavailability relative to thigh injection and a mean time to peak concentration of about 17 minutes.4PubMed Central. The Dorsal Forearm as a Novel Target for Intramuscular Injections: Clinical Pharmacokinetic Results With Naloxone For most laypeople, though, the nasal spray is simpler and requires no technique with needles.
Rescue Breathing and CPR
Naloxone alone is not always enough. In some overdose situations, the person’s breathing has already stopped long enough that their oxygen levels are dangerously low, and the heart may have slowed or stopped. The American Heart Association recommends that anyone who finds an unconscious person not breathing normally should begin CPR; if opioid overdose is suspected, naloxone should be administered alongside chest compressions.5Circulation. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses Earlier reviews of take-home naloxone programs also stressed that rescue breathing may be critical to survival in certain cases.6PubMed. Take-home naloxone to reduce heroin death
If you are trained in CPR, perform it. If you are not, hands-only CPR (pushing hard and fast on the center of the chest) is better than nothing. Once the person begins breathing on their own, roll them onto their side in the recovery position to prevent choking if they vomit, which is common during the wake-up process. Stay with them until paramedics arrive.
Why You May Need More Than One Dose
Naloxone’s effects wear off faster than most opioids last. Its duration of action is typically 30 to 90 minutes, while many opioids, especially long-acting formulations or high doses of fentanyl, remain active for far longer. This mismatch creates a real danger called “re-narcotization,” where the person initially revives but then slips back into overdose as the naloxone clears from their system while the opioid remains.7PubMed Central. Naloxone dosage for opioid reversal: current evidence and clinical implications This is why you must call 911 regardless of how well the person seems to recover. They need professional monitoring.
The fentanyl crisis has made multiple doses more common. Fentanyl is far more potent than heroin and saturates opioid receptors in the brain at very high levels. Naloxone needs to outcompete a massive number of occupied receptors, and a single standard nasal spray dose sometimes cannot do that.8PubMed Central. Higher doses of naloxone are needed in the synthetic opiod era A simulation-based clinical trial found that giving repeated intranasal doses at roughly two-and-a-half-minute intervals nearly doubled naloxone blood levels compared to a single dose, and stacking four doses over seven and a half minutes produced even higher concentrations.9JAMA Network Open. Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical Trial The practical takeaway: carry more than one dose, and keep giving it every two to three minutes if the person is not breathing on their own.
What Happens When Naloxone Works
Waking up from an opioid overdose is not pleasant. Naloxone strips opioids from receptors almost instantly, and in someone who is physically dependent, that triggers acute withdrawal. Symptoms can include a racing heart, anxiety, agitation, nausea, vomiting, sweating, and abdominal cramps. A prospective study of out-of-hospital naloxone administration at the 1.6 mg intramuscular dose found that about 39% of patients showed signs of opioid withdrawal, most commonly a fast heartbeat, mild agitation, and elevated blood pressure.10PubMed. Acute Opioid Withdrawal Following Intramuscular Administration of Naloxone 1.6 mg: A Prospective Out-Of-Hospital Series
This withdrawal is intensely uncomfortable but not life-threatening. The person waking up may be confused, combative, or frightened. Speak calmly, explain what happened, and try to keep them from leaving before paramedics arrive. Some people revived with naloxone become agitated enough to try to use opioids again immediately to stop the withdrawal symptoms, which is dangerous because the naloxone will wear off and the new dose could cause a second overdose. Emergency departments have begun using buprenorphine to ease naloxone-precipitated withdrawal symptoms, with case reports showing rapid improvement in withdrawal scores after a sublingual dose.11PubMed. Treatment of acute naloxone-precipitated opioid withdrawal with buprenorphine
Rare but Serious Complications
Naloxone is an extremely safe drug. A large study of pediatric emergency medical activations involving naloxone found that it worsened clinical status in just 0.2% of cases.12PubMed. Pediatric Emergency Medical Services Activations Involving Naloxone Administration But in rare instances, naloxone has been associated with noncardiogenic pulmonary edema, a condition where fluid floods the lungs. Case reports suggest this may be linked to the dose: one series described a patient who tolerated 2 mg of naloxone without issue but developed acute pulmonary edema after receiving 8 mg, supporting a dose-dependent relationship.13PubMed Central. Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series The proposed mechanism involves a sudden surge of adrenaline-like chemicals that shift blood volume into the lungs.14PubMed Central. Naloxone induced pulmonary edema
This is not a reason to hesitate in an emergency. The risk of death from an untreated overdose is vastly greater than the risk of a rare adverse reaction. The clinical message, as the American Heart Association has emphasized, is to titrate to the minimum dose that restores breathing rather than flooding the patient with as much naloxone as possible. For bystanders using pre-filled nasal sprays, this is already built into the dosing instructions: give one dose, wait, and repeat only if needed.
How Effective Are Community Naloxone Programs
Take-home naloxone programs, where kits are distributed to people who use drugs, their family members, and other potential bystanders, have been running for over two decades. A systematic review and meta-analysis of 44 studies published between 2003 and 2018 found that survival following bystander naloxone administration was about 98% in programs serving people who use drugs, and about 95% in programs serving their family members or other community members.15PubMed Central. Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis Survival rates did not differ by naloxone dose or route of administration. The message from two decades of data is clear: getting naloxone into the hands of people likely to witness an overdose saves lives at very high rates.
Where to Get Naloxone
In the United States, naloxone became available over the counter in 2023 when the FDA approved Narcan nasal spray for non-prescription sale. This was a significant shift, but availability in practice has been uneven. A national survey of over 1,100 pharmacies found that roughly 61% of those with naloxone in stock offered it without a prescription. The average cost was about $52, and the product was most often kept behind the pharmacy counter rather than on the shelf.16JAMA Network Open. Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status Chain pharmacies were more likely than independent pharmacies to have naloxone available for same-day pickup.17PubMed Central. Over-the-counter naloxone availability at North Carolina community pharmacies: A secret shopper study
Studies tracking the transition to over-the-counter status have found a meaningful increase in pharmacy willingness to dispense: in one study, the share of pharmacies willing to sell naloxone without a clinician-issued prescription jumped from about 53% before the OTC switch to about 71% afterward.18JAMA Health Forum. Naloxone Availability and Cost After Transition to an Over-the-Counter Product If your local pharmacy does not have it, community health organizations, syringe service programs, and many public health departments distribute naloxone for free. Some states also have mail-order programs. The $52 average retail cost is a real barrier for some people, but free options are widely available if you look.
Storing Your Kit
A common worry is that naloxone stored in a car glove box, a backpack, or a coat pocket will degrade from heat or cold. This concern is largely unfounded. A study that subjected naloxone ampoules to both sustained heat and repeated freeze-thaw cycles for up to 28 days found no meaningful changes in drug concentration compared to ampoules stored at room temperature.19PubMed Central. The effects of heat and freeze-thaw cycling on naloxone stability Naloxone is chemically sturdy. Check expiration dates periodically and replace expired kits, but do not let fear of imperfect storage conditions stop you from carrying one. A kit that has been through a few hot days in your car is far better than no kit at all.
Good Samaritan Laws and Calling 911
Fear of arrest is one of the biggest reasons people hesitate to call 911 during an overdose. Most U.S. states and many other countries have enacted Good Samaritan laws that provide some legal protection to people who call for help during an overdose, even if drugs are present at the scene. The problem is that awareness of these laws is strikingly low. A study in New York found that 85% of people who inject drugs were unaware of the state law’s protections for witnesses, and 83% did not know about protections for overdose victims who called 911.20World Medical & Health Policy. The New York 911 Good Samaritan Law and Opioid Overdose Prevention Among People Who Inject Drugs Fear of criminal penalties led some participants to delay calling or to abandon victims after dialing.
A similar pattern emerged in Indiana, where people who knew about Good Samaritan protections were more likely to have called 911 at a previous overdose.21PubMed Central. Lay responder naloxone access and Good Samaritan law compliance: postcard survey results from 20 Indiana counties Some people distrust that the law will actually be enforced as written, and qualitative interviews have revealed that even when people do call, they may leave the scene before help arrives.22PubMed. “Caught with a body” yet protected by law? Calling 911 for opioid overdose in the context of the Good Samaritan Law The evidence is consistent: the laws help, but only when people know about them and believe they work. If you carry naloxone, take a few minutes to look up your state’s Good Samaritan law so you know your protections before an emergency happens.
Nalmefene and What Comes Next
Naloxone is not the only opioid-reversing drug on the market. Nalmefene, which has a longer half-life and binds opioid receptors more tightly, has been explored as an alternative that could reduce the need for repeat dosing and lower the risk of re-narcotization.23PubMed Central. Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model-Based Evaluation of Important Pharmacological Attributes A randomized trial comparing the two drugs in emergency department patients found similar improvements in breathing and consciousness, with no significant difference in withdrawal symptoms between groups.24PubMed. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose
That might sound like a clear upgrade, but major toxicology organizations have urged caution. A joint position statement from the American College of Medical Toxicology and the American Academy of Clinical Toxicology recommended that nalmefene should not replace naloxone as the primary opioid antidote at this time. Their reasoning: comparative effectiveness data remain sparse, decades of safe experience favor naloxone, and nalmefene’s longer duration of action could cause more prolonged and severe withdrawal, which is itself a harm.25PubMed. American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time For now, naloxone remains the standard, and it is the drug you will find in virtually every community distribution program and pharmacy. The search for longer-acting alternatives reflects a real clinical gap, but the solution is still being worked out.